Zoetis Inc. logo

Zoetis Inc. (ZOE)

Market Open
5 Dec, 10:47
103. 36
-1.88
-1.79%
- Market Cap
29.76 P/E Ratio
1.73% Div Yield
255 Volume
5.79 Eps
105.24
Previous Close
Day Range
103.28 103.36
Year Range
100.48 170.88
Want to track ZOE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 69 days

Summary

ZOE trading today lower at €103.36, a decrease of 1.79% from yesterday's close, completing a monthly decrease of -17.97% or €22.64. Over the past 12 months, ZOE stock lost -34.14%.
ZOE pays dividends to its shareholders, with the most recent payment made on Dec 02, 2025. The next estimated payment will be in In 2 months on Mar 02, 2026 for a total of €0.5.
The last earnings report, released on Nov 04, 2025, missed the consensus estimates by -1.62%. On average, the company has fell short of earnings expectations by -0.54%, based on the last three reports. The next scheduled earnings report is due on Feb 12, 2026.
The stock of the company had never split.
The company's stock is traded on 14 different exchanges and in various currencies, with the primary listing on NYSE (USD).

ZOE Chart

Zoetis Inc. (ZTS) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

Zoetis Inc. (ZTS) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

Zoetis Inc. (ZTS) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

Seekingalpha | 20 hours ago
Zoetis (ZTS) Up 1.7% Since Last Earnings Report: Can It Continue?

Zoetis (ZTS) Up 1.7% Since Last Earnings Report: Can It Continue?

Zoetis (ZTS) reported earnings 30 days ago. What's next for the stock?

Zacks | 21 hours ago
Zoetis Stock Plummets 24.8% YTD: Here's What You Need to Know

Zoetis Stock Plummets 24.8% YTD: Here's What You Need to Know

ZTS faces steep YTD losses as safety concerns hit key osteoarthritis therapies, forcing revenue cuts while new approvals aim to stabilize growth.

Zacks | 23 hours ago

Zoetis Inc. (ZOE) FAQ

What is the stock price today?

The current price is €103.36.

On which exchange is it traded?

Zoetis Inc. is listed on NYSE.

What is its stock symbol?

The ticker symbol is ZOE.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1.73%.

What is its market cap?

As of today, no market cap data is available.

What is the earnings per share?

The EPS is 1.41.

When is the next earnings date?

The next earnings report will release on Feb 12, 2026.

Has Zoetis Inc. ever had a stock split?

No, there has never been a stock split.

Zoetis Inc. Profile

- Industry
- Sector
Kristin C. Peck CEO
XSTU Exchange
US98978V1035 ISIN
US Country
13,800 Employees
31 Oct 2025 Last Dividend
- Last Split
1 Feb 2013 IPO Date

Overview

Zoetis Inc. is a global leader in the discovery, development, manufacture, and commercialization of a wide range of animal health medicines, vaccines, and diagnostic products. Founded in 1952 and based in Parsippany, New Jersey, the company addresses the health needs of both livestock—including cattle, swine, poultry, fish, and sheep—and companion animals, such as dogs, cats, and horses. With a presence in both the United States and international markets, Zoetis delivers products and services designed to meet the complex challenges of animal health, ensuring the well-being of animals across the globe. The company's extensive product line-up, alongside innovative diagnostic solutions, makes it a vital player in promoting animal health and supporting the veterinarians, livestock producers, and pet owners who care for them.

Products and Services

Zoetis Inc. offers an expansive portfolio of products and services designed to enhance animal health and support the professionals who work with animals. These include:

  • Vaccines: Zoetis provides biological preparations that protect against diseases of the respiratory, gastrointestinal, and reproductive tracts. These vaccines induce a specific immune response in a variety of animals, helping prevent outbreaks and the spread of infectious diseases in both livestock and companion animals.
  • Anti-infectives: These products are formulated to prevent, kill, or slow the growth of harmful bacteria, fungi, or protozoa. By offering a range of anti-infectives, Zoetis contributes to the overall health and well-being of animals, helping to combat infections before they become widespread issues.
  • Parasiticides: To protect animals from external and internal parasites, Zoetis commercializes treatments that eliminate or prevent infestations such as fleas, ticks, and worms. These products are critical in maintaining animal health and preventing the transmission of parasite-borne diseases to other animals and humans.
  • Other Pharmaceutical Products: Beyond vaccines and parasiticides, Zoetis offers a variety of pharmaceutical products addressing pain and sedation, antiemetic therapies, reproductive health, and oncology in animals. Additionally, the company provides dermatology products for conditions such as allergic dermatitis, ensuring comprehensive care for a wide range of health needs.
  • Medicated Feed Additives: These products mix medicines with livestock feed to prevent or treat disease and enhance overall animal health. Medicated feed additives are a critical component in the maintenance of healthy commercial herds and flocks.
  • Diagnostic Products: Zoetis delivers a variety of diagnostic solutions, including portable blood and urine analysis testing kits, point-of-care products, and instruments. These diagnostic tools are vital for early detection of disease and condition management in animal healthcare settings.
  • Non-Pharmaceutical Products and Services: In addition to its pharmaceutical offerings, Zoetis provides nutritionals and agribusiness services, products for biodevices, genetic tests, and precision animal health solutions. These products and services support the broader aspects of animal care and health management.

Contact Information

Address: 10 Sylvan Way
Phone: 973 822 7000